A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer
Menée sur 37 patients atteints d'une tumeur germinale non séminomateuse du testicule de stade I et traités entre 2006 et 2014, cette étude compare l'efficacité, du point de vue de données intra- et péri-opératoires (durée de l'opération, perte de sang, nombre de ganglions collectés, ...), et la sécurité de deux techniques de curage ganglionnaire rétropéritonéal, l'une par laparoscopie standard et l'autre par laparoscopie assistée par robot
Objective : To compare the safety and perioperative outcomes of robotic retroperitoneal lymph node dissection (R-RPLND) vs laparoscopic RPLND (L-RPLND). Patients and Methods : Our Institutional Review Board-approved retrospective testicular cancer registry was queried for patients who underwent a primary unilateral R-RPLND or L-RPLND by a single surgeon for a stage I testicular non-seminomatous germ cell tumour. Groups were compared for differences in baseline and outcome variables. Results : Between July 2006 and July 2014, 16 R-RPLND and 21 L-RPLND cases were performed by a single surgeon. Intra- and perioperative outcomes including operative time, estimated blood loss, lymph node yield, complicate rate, and ejaculatory status were similar between groups (all P > 0.1). Conclusions : As an early checkpoint, R-RPLND appears comparable to L-RPLND in terms of safety and perioperative outcomes. It remains unclear if R-RPLND offers any tangible benefits over standard laparoscopy.